Grenada vs Sur: New cases tested for RR-/MDR-TB

Grenada
100.0%
in 2024
Sur
97.0%
in 2024
Grenada rank
1st
Sur rank
1st

New cases tested for RR-/MDR-TB over time

  • Grenada
  • Sur
020406080100200520142024

How they compare

Grenada currently reports 100.0% against 97.0% in Sur, a difference of 3.0%.

The two have swapped places 5 times across 10 shared years of data; in 2015 it was Sur ahead.

Grenada ranks 1st and Sur ranks 1st of 192 countries.

Sur has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Grenada Sur Difference Ahead
2010s 46.6% 91.2% 44.6% Sur
2020s 35.0% 97.2% 62.2% Sur

Averages of every year both report within each decade.

Frequently asked questions

Which has higher new cases tested for rr-/mdr-tb, Grenada or Sur?
Grenada, at 100.0% against 97.0% in Sur as of 2024.
What is the difference in new cases tested for rr-/mdr-tb between Grenada and Sur?
3.0%, with Grenada ahead.
How many years of comparable data are there for Grenada and Sur?
10 years are reported by both, from 2015 to 2024.
How do Grenada and Sur rank globally for new cases tested for rr-/mdr-tb?
Grenada ranks 1st and Sur ranks 1st of 192 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Grenada vs Sur: New cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 23 August 2026, from https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/grenada/sur/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/grenada/sur/">Grenada vs Sur: New cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
204 places, 3,368 data points, 2005–2024
Last refreshed